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doi:10.1016/j.ejvs.2010.06.011Abstract Objective: To investigate the efficacy of A-V impulse technology (A-V) for oedema
prevention and treatment following PTFE femoropopliteal surgery.
Design: Prospective randomized clinical trial.
Materials: 36 patients undergoing PTFE femoropopliteal bypass reconstructions, either being
treated postoperatively with a compression stocking (CS) (Group-1, n Z 19) or with A-V
(Group-2, n Z 17).
Methods: Patients in treatment group-1 used a CS postoperatively during 1 week day and night,
patients in group-2 were treated with A-V postoperatively at night during one week. The lower
leg circumference was measured preoperatively and at five postoperative time points.
Results: Limb circumference has increased postoperatively on day 1 (CS 1.5%/A-V 1.4%), on
day 4 (5.7%/6.3%), on day 7 (6.6%/6.1%), on day 14 (7.9%/7.7%) and on day 90 (5.8%/5.2%).
Differences between treatment groups were not significant. A re-operation gives a significant
3.9% increase in circumference as compared to a first operation (95% CI: 1.5e6.4%; pZ 0.002).
Conclusion: No significant differences were found in the extent of developed edema between
the groups following PTFE femoropopliteal bypass surgery. A redo peripheral bypass operation
results in significantly more postoperative oedema than a first-time performed bypass opera-
tion.
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636 A. te Slaa et al.In selected patients suffering from severe peripheral Inclusion criteria
arterial disease (PAD), an artificial femoropopliteal bypass
might be constructed. An artificial graft is indicated when
a patient does not have a suitable vein to be used as
graft.1 The material used for an artificial graft can be
polyethylene terephthalate (Dacron) or polytetrafluoro-
ethylene (PTFE). There is no evidence of superiority of
one material over the other.2 Postoperative oedema
occurs in a majority of patients, who are treated with
a femoropopliteal bypass.3e9 Following successful revas-
cularisations, patients do regularly report discomfort from
postoperative oedema. Postoperative oedema might delay
rehabilitation and prolong hospital stay. Postoperative
oedema is also known to impair macrovascular and
microvascular circulation and wound healing.10 The
pathophysiology of post-reconstructive oedema is thought
to be a combination of hyperaemia,11 increased capillary
permeability10,12 and lymphatic3,5,7,9 and venous disrup-
tions.7,14,15 Postoperative oedema typically lasts for
3 months.16 In general, the treatment of lower limb
oedema is based on leg elevation, the use of external
compression stockings (CSs)17 or lymph drainage.18
Following peripheral bypass surgery, external compres-
sion is mostly based on clinical experience, because
prospective trials regarding the efficacy of the use of
stockings following bypass surgery are lacking. Post-
operative limb oedema occurs as well after orthopaedic
and trauma surgery. The use of A-V impulse technology, an
intermittent pneumatic compression device (IPC) on the
foot, has been proven effective to reduce this oedema.19
IPC is also known to increase arterial inflow and pressure
in the lower limb in patients suffering from PAD.20
The primary aim of this study is to investigate the effect
of A-V impulse technology as a treatment method to reduce
post-revascularisation oedema. Improvements in oedema
reduction strategies might accelerate postoperative reha-
bilitation and improve wound healing. A second aim of this
study is to detect differences in postoperative C-reactive
protein (CRP) and leucocyte concentrations between
treatment strategies, which are of interest as increases in
inflammatory parameters are associated with events and
mortality in vascular patients.21,22 A third aim of this study
is to investigate the effect of a redo bypass operation
compared with first-time bypass operation on oedema
development.
Methods
Study design
A prospective randomised controlled trial was performed in
a non-academic teaching hospital in the Netherlands
between 2006 and 2009. The work-up included an ankle-
brachial pressure index (ABI), a walking test, a venous and
arterial duplex ultrasound assessment and either a digital
subtraction angiography (DSA) or a magnetic resonance
angiography (MRA) scan. The medical ethical board of the
hospital approved the protocol. All patients gave their
written informed consent preoperatively. Randomisation
was done postoperatively in a two-by-two order. The ran-
domisation strategy was unknown to the surgical team.All patients included were suffering from PAD Rutherford
category 3e6 on principal lower limb vessels or crural
vessels, as defined by the international (Inter-Society
Consensus for theManagement of Peripheral Arterial Disease
(TASC II)) consensus criteria.23 None of the patients was
eligible for endovascular treatment options. PTFE grafting
was indicated due to the inability to construct an autologous
bypass. This inability was due to the absence of a suitable
vein to be used as a bypass on either the affected or the
contralateral leg, or due to loss of patency of a prior-per-
formed autologous bypass reconstruction (> 1 year before).
There was an unobstructed iliac inflow and there was suffi-
cient outflow through at least one crural vessel based on
duplex, DSA or MRA findings gathered preoperatively.
Exclusion criteria
Patients suffering from severe cardiac failure (New York
Heart Association (NYHA) class-III and IV) were excluded due
to the haemodynamic effects of IPC that are not completely
understood. Patients with known deep-vein thrombosis or
pulmonary embolism on admission were not included for the
same reason. Patients who demanded haemodialysis due to
severe renal impairment were excluded. So were patients
who experienced pre-existing limb oedema due to severe
liver impairment (ChildePugh score B and C), venous insuf-
ficiency, endocrinological diseases or who experienced
manifest oedema caused by medication. Patients with large
ulcers (>3 cm2) on the plantar aspect of the foot or who had
undergone amputations that would compromise the fit of the
IPC pad were excluded. Further exclusion criteria were
known malignant diseases, enrolment in other trials and
mental inability to understand the contents of the trial.
Surgical procedure
Surgery was performed under general and/or spinal
anaesthesia. A deep-tunnelled Distaflo (Bard Peripheral
Vascular Inc., Tempe, AZ, USA) PTFE supragenicular or
infragenicular femoropopliteal bypass was constructed.
The Distaflo graft is used as our standard graft for all
peripheral revascularisations. A standardised medial inci-
sion was made in the groin at the site of the bifurcation of
the femoral artery. The popliteal dissection was made
above or below the knee. Smaller lymphatic structures
were coagulated, while larger lymphatic structures were
ligated using Vicryl (Ethicon Inc., Somerville, NJ, USA).
Patients underwent systemic heparinisation (5000 IE) during
the operation. The iliac inflow was checked prior to
revascularisation. The grafts were implanted endtoside.
A routine Doppler assessment was performed before
closure of surgical wounds. The use of acetylsalicylic acid
(ASA) was initiated or continued postoperatively.
Treatment groups
The control group patients (group-1) used the current
postoperative protocol. These patients received graduated
CSs above the knee (BREVET-tx, Mo¨lnlycke, Go¨teborg,
Table 1 Baseline characteristics.
Variable CS
group
A-V group
N 19 17
Age, mean (range) 72 (46e84) 71 (40e86)
Sex, Male/Female 13/6 11/6
Indication for operation,
Rutherford 3/4/5e6
6/5/8 2/8/7
ABI, mean (SD) 0.43 (0.14) 0.51 (0.21)
ABP, mean (SD) 149 (29) 147 (23)
Risk factors
Diabetes 5 7
Serum Cholesterol
(mmol/L) (SD)
5.3 (1.6) 4.5 (1.2)
eGFR (mL/min/1.73 m2) (SD) 77 (29) 72 (24)
Liver impairment 0 0
Positive family history of
cardiovascular disease
11 6
Smoking, current or recent 11 6
Medication
Calcium channel blockers 10 4
Vasodilatators 6 2
NSAID 1 2
Estrogens 0 1
ABI; ankle-brachial pressure index, ABP; arterial blood pres-
sure, eGFR; estimated glomerular filtration rate.
Evaluation of A-V Impulse Technology 637Sweden) postoperatively. The stocking delivers 18 mm Hg of
pressure (class-I CS) on the foot and features low-pressure
areas on the heel and over the popliteal vein. Patients were
hospitalised for 1 week. During this period, the patients
wore the stocking on the affected limb day and night. After
their discharge from hospital, group-1 patients used the CS
only during the day. Group-2 patients received the A-V
impulse technology (Orthofix Vascular Novamedix, Andover,
UK) on the affected limb during the night, from 20:00 to
08:00 h, during 1 week in hospital. Starting the 2nd week,
group-2 patients wore CSs (as mentioned for group-1) until
the 8th week after surgery during the day as well.
A-V impulse technology
The A-V impulse technology is an IPC device. It works by
pumping intermittently compressed air into a pad that fits
the foot. The pad flattens the plantar arch of the foot on
inflation, thereby deflating the venous plexus. The pad is
inflated in 0.4 s, by which time, a pressure is built up to
130 mm Hg. Deflation occurs through perforations in the
pad. The cycle of 20 s allows for efficient priming of the
venous pump.19 The sudden inflation impulses reproduce
the physiological ratchet-like flow pattern of venous
return.
Measurements
Lower limb circumference measurements were performed
at six different time points: the day prior to surgery and
1 day, 4 days, 7 days, 2 weeks and 3 months after surgery.
The repeated limb measurements were done by using
a tape measure.24 At each time point, the wound condition
was also assessed. Leucocyte counts and CRP concentration
measurements were performed at four points of time: the
day prior to surgery and 1 day, 7 days and 2 weeks after
surgery. Patients were hospitalised during the first week
after surgery. At day 4 and at 3 months Ankle-brachial index
(ABI) was repeated. After 3 months, a duplex ultrasound
assessment was performed to check the bypass for in-graft
stenosis or obstruction.
Intention to treat
This study was carried out on an ‘intention-to-treat’ basis.
Patients were encouraged to carefully mobilise from the
first postoperative day, if possible. No restrictions were
placed on early rehabilitation schedules. Group-1 patients
who used CS mobilised while wearing their stocking. Group-
2 patients were not able to mobilise when the A-V impulse
technology device was active. Group-2 patients who did not
tolerate or experienced discomfort from the A-V impulse
technology were offered a CS and vice versa. Patients
experiencing postoperative complications were treated
according to common medical insights. Occurring compli-
cations did not result in exclusion from analysis unless they
were lost in follow-up in the first postoperative week.
A duplex ultrasound assessment was performed prior to
3 months if there was suspicion for in-graft stenosis of
obstruction. Original grouping was maintained in the data
analysis.Statistical analysis
Due to a lack of information on the magnitude of a differen-
tial treatment effect on lower limb circumference, the
power analysis performed prior to the trial was based on
a Cohen’s dZ 0.90, representing a large effect size.25 This
effect is detectable with 80% power with 20 patients eligible
per group and a test size of 0.05 (two-sided). Statistical
analysis was performed with Statistical Package for Social
Sciences program (SPSS) 15.0 software (SPSS Inc., Chicago,
IL,USA). Thenine circumferencemeasurements at each time
point in each patient were averaged after logarithmic
transformation. The choice of a natural logarithmic trans-
formation of the circumference measurements prior to
analysis was made for practical reasons: (1) on the log scale,
circumference measurements are linearly related to the
section area and volume of a cylinder; and (2) a change or
difference on the log scale can be back-transformed to
a percentage as a common effect measure in this field.
Leucocyte counts and CRP concentrations were logarithmi-
cally transformed aswell because of the positive skewness of
their distribution. The data were analysed using mixed-
model analysis of variance (ANOVA). A restricted maximum
likelihood method was used for testing and estimating the
various effects. This method is known to be able to correctly
deal with missing observations. The dependent variable is
the average logarithmically transformed circumference, as
just defined. The following independent variables were
taken into account for explaining circumference: a between-
subject factor ‘group’ (two levels: CS and A-V), a within-
subject factor time since baseline (five levels: 1, 4, 7, 14 and
Table 2 Bypass graft characteristics.
Reconstruction
characteristics
CS
group
A-V group
Distal anastomosis
Supragenicular 6 6
Infragenicular 8 8
Re-operation 6 3
Saphenous vein
Absent 6 5
Small-caliber 13 12
Operation time
(min) (SD)
161 (33) 143 (40)
Necessity for blood transfusion 0 1
638 A. te Slaa et al.90 days) and the baseline covariates circumference and
re-operation (yes/no). By entering the appropriate interac-
tion terms in the model, we simultaneously tested the
modification by time of the effect of the baseline covariates
and the modification of the (evolution of the) treatment
effect by the baseline covariates. Eventually, the ‘group-by-
time’ interaction factor was also tested. The estimated
differences between treatment groups and within-subject
changes frombaseline and their 95% confidence intervals (CI)
were back-transformed by exponentiation so as to obtain
percent differences and changes in circumferencewith their
95% confidence limits. In the analysis, no structure was
imposed on the (co)variances of the five repeated measure-
ments. Similar analyses were done for CRP and leucocyte
counts.
Categorical variables were compared between two
groups using Fisher’s exact test. A value of P < 0.05 denotes
statistical significance.Results
Between 2006 and 2009, 39 patients received a PTFE femo-
ropopliteal bypass reconstruction due to severe PAD. Data
from 36 patients were analysed. Three patients were
excluded from analysis. Two of these three patients under-
went an amputation in the first week following surgery and
the other patient died in the first week following surgery.
Nineteen patients were randomised in group-1 (CS) and 17Figure 1 Percent increase of averaged lower limbpatients were randomised in group-2 (A-V impulse tech-
nology). Baseline characteristics are outlined in Table 1.
Surgical characteristics are outlined in Table 2. There were
no substantial imbalances between the treatment groups.
After surgery, an increase in the leg circumference was
measured in both groups (Fig. 1); see the summary statistics
of the raw data in Table 3. From the mixed-model ANOVA, it
appeared that there is a significant (P < 0.0005) effect of
baseline circumference on circumference later in time in
both groups. Further, a re-operation gives a significant 3.9%
increase in circumference as compared with a first opera-
tion (95% CI: 1.5e6.4%; PZ 0.002), given measurement day
and treatment group (Figs. 2). Testing the appropriate
interaction terms in the mixed-model ANOVA gave no
indication that these effects are modified by time, or that
the (evolution of the) treatment effect is modified by these
baseline covariates (chi squareZ 23.124; 18 df; P Z 0.19).
The results of a model fitted without these interaction
terms are presented in Table 4. At none of the five
measurement days is a significant difference in circumfer-
ence between the two treatments seen, using t-tests (P-
values ranging from 0.20 to 0.99), which is corroborated by
an overall F-test (F (5,30)Z 0.532; PZ 0.75), adjusted for
baseline circumference and the re-operation effect. As the
estimated treatment effects (A-V vs CS) also do not signif-
icantly vary across the measurement days (F
(4,32)Z 0.659; PZ 0.63), a common effect of A-V vs CS on
circumference can be estimated at þ0.16% (95% CI: 1.81%
to þ2.16%; PZ 0.87), adjusted for baseline circumference
level and the re-operation effect. Three patients using the
A-V impulse system did not tolerate the device. These
patients were further treated with CS. All patients who
used the CS tolerated them.
Changes in leucocyte counts and CRP concentration are
plotted in Figs. 3 and 4. Differences in leucocyte counts and
CRP concentration between the groups were not significant
at any time point and for the whole model. There was
a significant increase in leucocyte counts after surgery from
the baseline (preoperative), except in the stocking group
on day 7. The increase (from the baseline) in the CRP
concentration was significant in both groups post-
operatively on day 1 and day 7, but not on day 14. There
were no significant correlations between circumferential
measurements and leucocyte counts or CRP concentrations
at any time.circumference with standard deviation markers.
Table 3 Summary statistics of circumference (cm) and its percent change from baseline across the two patient groups at the
various measurement days.
Day Group Level (cm) Change (%) from baseline
N Mean SD Median Min. Max. Median Min. Max.
1 CS 18 29.0 3.7 29.5 22.0 37.0 0 0 0
A-V 17 29.6 3.5 31.2 23.7 33.8 0 0 0
1 CS 18 29.6 3.8 30.6 21.5 36.8 1.5 e8.3 8.7
A-V 17 30.0 3.4 31.2 24.5 35.2 2.0 e10.5 6.5
4 CS 18 30.7 3.7 31.1 23.7 37.7 6.6 e1.3 28.5
A-V 17 31.4 3.2 32.4 24.5 35.1 5.1 e4.9 20.3
7 CS 19 30.9 3.3 30.7 23.9 36.9 8.0 e3.0 14.1
A-V 17 31.3 2.8 31.5 25.9 35.4 6.4 e8.2 18.6
14 CS 19 31.3 3.6 31.6 24.5 38.4 6.7 e3.6 16.2
A-V 15 31.4 3.0 32.2 25.8 36.7 7.3 e0.2 23.7
90 CS 16 30.4 3.1 30.7 24.0 36.1 5.9 e1.2 13.6
A-V 13 31.1 3.4 31.5 26.6 36.8 5.7 e0.9 17.1
Evaluation of A-V Impulse Technology 639Relevant complications are shown in Table 5. Two
patients died before the 14th day (one in both groups) and
two patients underwent an amputation before the 14th day
(one in both groups). There were six wound infections
(three in both groups). No significances were found in the
occurrence of complications between the groups.Discussion
Oedema developed irrespective of the use of CS or the A-V
impulse technology, following femoropopliteal PTFE bypass
grafting. The null hypothesis that there is no difference in
circumference between the groups across all time points
could not be rejected. In this randomised trial, oedema was
observed and quantified. Oedema developed in all patients
following PTFE bypass surgery, which is in accordance with
findings in literature.5,7e9 Patients, who underwent a redo
bypass operation, developed significantly more and longer
lasting oedema than patients who underwent first-time
PTFE bypass surgery. These findings have not been reported
before in literature.
Indications for peripheral bypass revascularisations have
narrowed as newer minimally invasive techniques haveFigure 2 Percent increase of averaged lower limb circumferen
operation.been widely introduced. The ‘intention-to-treat’ basis
underlying this trial implied that patients were treated
according to up-to-date medical insights. What is more,
patients were revascularised using an autologous bypass
graft whenever possible.1 These factors did attribute to
‘small numbers’. Patients who underwent a re-operation
experienced loss of patency of an autologous femo-
ropopliteal bypass in their case history. All patients who
underwent first-time PTFE grafting had a small-calibre
saphenous vein, unsuitable to for use as an autologous
bypass graft.
It is known from literature that increased leucocyte
counts and CRP concentrations correlate with higher
morbidity, mortality and cardiovascular events.21,22 A
difference in our primary endpoint, post-revascularisation
oedema, could have led to a difference in leucocyte counts
and CRP concentrations. However, in our study, both the
extent of post-revascularisation oedema, and leukocyte
counts and CRP concentrations did not differ significantly
between the groups. Further, no differences in the occur-
rence of wound infections between the groups could be
found.
The power calculation underlying the design of this
trial was based on large treatment effects once with standard deviation markers following a redo bypass
Table 4 Point and interval estimates of percent changes from baseline and percent differences in circumference between the
treatment groups, adjusted for the baseline circumference level and re-operation effect, resulting from mixed-model ANOVA.
Day Group % Change from baseline A-V vs. CS (%)
Estimate 95% CI Estimate p-Value 95% CI
Lower Upper Lower Upper
1 CS 1.30 1.03 3.68 0.33 0.84 e2.92 3.70
A-V 1.64 0.70 4.03
4 CS 7.13 4.63 9.69 1.01 0.54 e4.32 2.41
A-V 6.04 3.50 8.65
7 CS 6.38 4.25 8.56 0.02 0.99 e2.90 2.93
A-V 6.36 4.16 8.60
14 CS 6.69 4.12 9.33 2.27 0.20 e1.25 5.93
A-V 9.12 6.41 11.89
90 CS 5.51 3.61 7.43 0.15 0.91 e2.49 2.87
A-V 5.67 3.62 7.76
Overall p-value 0.75
640 A. te Slaa et al.circumference in terms of Cohen’s d. However, at none of
the measurement days was a significant treatment
difference seen, nor an assumed common treatment
difference across the five measurement days. The 95% CI
of the treatment difference should also be taken into
account in the interpretation of such a result. The lower
and upper limit of the CIs give an indication of the
minimum and maximum true treatment effect that may
have been overlooked (due to a type-2 error), given the
sample size of this study. This roughly implies that a true
common effect of A-V impulse vs CS smaller than 2% or
larger than þ2% would have been detectable with the
sample size of this trial.
Oedema following femoropopliteal surgery is likely to be
of multifactorial origin with a large contribution of
lymphatic disruptions.5,7,9,13 Surgical damage or functional
impairment due to inflammatory processes or adjacent
tissue trauma could affect the lymphatics.9 Studies that
have focussed on lymph-sparing methods to reduce post-
operative oedema are not conclusive. All patients were
operated on using a standardised medial approach. There-
fore, it is unlikely that the approach could have been of
influence on the endpoints.7,9 Lymphatic function does
restore as damaged lymphatic channels rejoin and newFigure 3 Percent increase in CRP concentlymphatic channels are formed.6,16 When we presume that
the lymphatics have rejoined or that new lymphatics have
been formed in the group of re-operated patients, then it
cannot be ruled out that venous disruptions do attribute to
oedema formation. Such findings correspond to findings of
an increased magnitude in oedema formation, following
both arterial and venous injury.14,15 On the other hand, it
may also be possible that re-operations might lead to
further lymphatic damage in scarred tissue. This study does
not reveal new insights into theories concerning hyper-
aemia and an increased capillary filtration as a cause of
postoperative oedema.
In our trial, we used a graduated (class-I) CS above the
knee, exerting up to 18 mm Hg pressure to the limb. The
use of CSs postoperatively is mostly based on clinical
experience. We used a class-I stocking, because class-II
stockings and above might exert too much pressure on the
leg, possibly resulting in even more patient discomfort or
graft failure. The working mechanism of the CS is to
increase pressure on the interstitial space17 and to augment
the peripheral circulation by lowering the flow resistance at
the arteriolar level.26
When an IPC device is active, it attributes to the arte-
rial27 and venous blood flow.28 The A-V impulse techniqueration with standard deviation markers.
Figure 4 Percent increase in leukocyte concentration with standard deviation markers.
Evaluation of A-V Impulse Technology 641has also been tested successfully for oedema reduction
following orthopaedic and trauma surgery on the lower
limb.19 The use of A-V impulse technology could not
prevent postoperative oedema from occurring in a lesser
extent compared with the use of CSs following PTFE fem-
oropopliteal bypass surgery. This was disappointing with
respect to what could be expected based on the results
after orthopaedic and trauma surgery.19 The A-V group
patients in our study only used the system during the night.
Application of A-V impulse technology during the day would
compromise early mobilisation and therefore conflict with
‘intention-to-treat’ basis of this trial. However, non-use of
CSs during the day might have contributed to oedema in
these patients.
This trial has been set up to investigate the efficacy of
A-V impulse technology following PTFE femoropopliteal
surgery in a controlled situation. A lack of knowledge
regarding haemodynamic effects in recently operated
patients restrained us from continuing the use of A-V
impulse technology after discharge from hospital. In future
trials, A-V impulse technology might be used over a pro-
longed period. A solution to promote arterial blood flow,
and thereby decreasing the risk of early in-graft stenosis or
occlusion, as well as to reducing oedema, might be to
combine A-V impulse technology with external compression.Table 5 Complications. Patients in group-1 used the
compression stocking. Patients in group-2 used the AV-
impulse technology.
Complication CS
group
A-V group
Wound infection 3 3
Infection (other origin than
wound)
1 1
Hematoma 1 0
Persisting seroma (>3 months) 1 0
Lymphocutanous fistula 0 0
Occlusion 5 3
Hyper-perfusion syndrome 0 0
Amputation 1 1
Death 1 1The successful use of IPC in unsupervised conditions has
been proved by Delis et al. on patients suffering from
intermittent claudication.27Conclusion
Postoperative oedema developed in all patients who
underwent PTFE femoropopliteal bypass surgery. No
significant differences in the extent of oedema could be
detected between patients who used compression stocking
and those who used A-V impulse technology post-
operatively, nor were differences in increased inflamma-
tory parameters detected between treatment groups.
Patients who underwent a redo operation with a PTFE graft
(due to a failed autologous graft) developed significantly
more oedema than patients who underwent first-time PTFE
grafting. The use of CSs has been the standard practice
postoperatively. This trial on the effect of A-V impulse
technology, which was expected to treat and prevent
postoperative oedema effectively, concluded that it gave
results similar to CSs. The use of A-V impulse technology
following PTFE femoropopliteal surgery should be further
investigated.
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